Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report

C. Annaloro(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Elena Tagliaferri(University of Milan), Gabriella Mometto(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesco Onida(Peter MacCallum Cancer Centre), Giorgia Saporiti(University of Milan), Antonella Costa(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Nicola Stefano Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Silvia Artuso(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Federica Irene Grifoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Clinical Case Reports
June 11, 2015
10.1002/ccr3.308
Cited by 16

Related Papers

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373